Search results
Showing 3361 to 3375 of 8235 results
People have the right to be able to make informed decisions about their care. Our guidance should be taken into account when making decisions with them.
This guidance evaluates digital technologies, diagnostics and medical devices (including artificial intelligence).
The NICE commercial liaison team aim to reduce the workload for the NHS and frontline staff by making commercial agreements more straightforward.
Before 2022, we used different processes for assessing technologies. You can view the previous process and methods guides below.
How providers and commissioners can use quality standards to improve the quality of care
We assess the efficacy and safety of interventional procedures used for treatment or diagnosis to determine whether they work well enough and are safe enough for use in the NHS.
The Office for Digital Health strives to accelerate NICE's efforts to deliver innovation to the health and care system.
A joint NICE and NHS England meeting can help to ensure you're ready for NHS patient access and subsequent NICE appraisal
We use 3 processes for assessing technologies: the single technology appraisal, the multiple technology appraisal and the cost comparison appraisal
Home What NICE does Our research work HTA Lab...
Evidence standards framework (ESF) for digital health technologies
NICE standards for innovators of digital health technologies and NHS commissioners
Get expert advice and support from NICE International, part of the UK's National Institute for Health and Care Excellence, for a project in your country
Our indicators measure outcomes that reflect the quality of care or processes linked by evidence to improved outcomes.
Our quality standards set out priority areas for quality improvement in health, public health and social care.
A timeline showing where in the NICE evaluation process companies will be charged.